Home›Stock Screener›Kopran

Kopran Share Price Today | Stock Price & Kopran Share Screener

KOPRAN Pharmaceuticals & Biotechnology
Live Share Price NSE
₹267.05
▲ 1.12 (0.42%)
2026-11-19 00:00:00
Live Share Price BSE
₹266.45
▲ 0.95 (0.36%)
2026-11-19 00:00:00

As of November 19, 2026, the live Kopran share price (NSE: KOPRAN) is ₹267.05 on NSE and ₹266.45 on BSE, up 0.42% from the previous close, with shares trading between ₹263.81 and ₹272.10 in today's trading session, and a 52-week range of ₹108.04–₹290.90. Track Kopran market cap to gauge the company's total market size. Use the Kopran stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Kopran opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹212 and net income of ₹4, with EBITDA of ₹16, an operating margin of 7.0% and a profit margin of 1.9%.

Kopran Market Cap ₹1,395.85 Cr.
KOPRAN P/E Ratio (TTM) 34.50
Kopran P/B Ratio 2.57
EPS (TTM) ₹5.33
Dividend Yield 1.07%
Debt to Equity 0.29
KOPRAN 52 Week High ₹290.90
Kopran 52 Week Low ₹108.04
Operating Margin 7.00%
Profit Margin 1.89%
KOPRAN Revenue (TTM) ₹212.00
EBITDA ₹16.00
Net Income ₹4.00
Total Assets ₹908.00
Total Equity ₹530.00

Kopran Share Price Chart

Track the current stock price of Kopran with an interactive chart. Analyse KOPRAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kopran stock quote in one place.

The quote of ₹267.05 sits between the 52-week low of ₹108.04 and the 52-week high of ₹290.90, and the latest session moved 0.42% from the previous close.

Kopran Company Profile - Fundamental Screener

Screen Kopran company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KOPRAN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE082A01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE082A01010

Kopran Balance Sheet Screener

Screen KOPRAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹908, up from ₹844 in 2025.

Latest statistics put total assets at ₹908 and shareholder funds at ₹530, with a leverage ratio of 0.29.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 908 844 743 650 611 439 371 352 316 298
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 346 208 182 165 151 112 111 113 104 105

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 32 37 34 34 33 34 42 49 35 37
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 530 518 491 439 426 245 190 169 145 125
Share Capital 48 48 48 48 48 43 43 43 43 43
Reserves & Surplus 482 470 443 391 378 202 146 125 102 81

Kopran Income Statement Screener - Profit & Revenue Analysis

Screen Kopran income statement and profit fundamentals. Analyze KOPRAN quarterly results. Kopran reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹212 and net profit was ₹4, equal to earnings per unit of ₹0.91, at an operating margin of 7%.

In that period expenses were ₹196, interest cost ₹4 and tax ₹2. The next period listed, 2026-Jun, shows revenue of ₹156 and net profit of ₹7.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 212 156 234 194 118 138 176 166 153 142 196 161 153 119 153
Expenses 196 138 201 177 123 121 155 146 137 121 164 135 130 111 137

Operating Costs and Margins

EBITDA 16 18 33 18 -5 17 20 20 16 21 31 26 23 9 16
Operating Profit % 7.00% 10.00% 14.00% 9.00% -4.00% 10.00% 10.00% 12.00% 10.00% 13.00% 12.00% 15.00% 15.00% 5.00% 8.00%
Depreciation 6 6 5 4 4 4 4 4 4 4 4 3 3 3 3
Interest 4 3 3 3 2 3 3 2 2 2 3 2 2 2 2

Profit and Earnings

Profit Before Tax 6 9 25 11 -12 10 14 14 10 15 25 21 18 4 11
Tax 2 2 7 1 -2 2 4 4 2 4 7 5 5 1 3
Net Profit 4 7 19 9 -10 7 10 10 7 11 19 16 14 3 8
EPS 0.91 1.39 3.91 1.93 -2.06 1.54 2.00 2.16 1.53 2.30 3.86 3.28 2.86 0.58 1.67

Kopran Cash Flow Screener - Liquidity Fundamentals

Screen KOPRAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹67, and net cash flow was an outflow of ₹19.

Over the same period, investing activities used ₹65 and financing activities used ₹21.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 67 42 43 34 -34 60 31 25 26 16
Investing Activities -65 -56 -44 -13 -84 -25 -13 -25 -11 -18

Financing and Net Cash

Financing Activities -21 26 1 -20 123 -35 -18 -1 -15 2
Net Cash Flow -19 11 1 2 5 0 0 0 0 0

Kopran Shareholding Pattern Screener

See Kopran shareholding pattern with promoter, FII, and DII holdings. Check Kopran promoter holding and ownership changes for KOPRAN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 44.42%, foreign institutions 0.57%, domestic institutions 0.00% and the public 44.08%, spread across 58,639 shareholders.

The shareholder count was 58,639 in 2026-Mar, compared with 56,925 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 44.42% 44.42% 41.82% 44.42% 44.42% 44.42% 44.42% 44.49%

Institutional Investors

FII Holding 0.57% 0.51% 0.91% 1.12% 0.76% 0.60% 0.36% 0.84%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.20%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 44.08% 44.14% 46.34% 41.36% 42.83% 44.65% 44.71% 37.98%
Other Holding 10.92% 10.92% 10.93% 13.10% 11.99% 10.33% 10.51% 15.49%
Shareholder Count 58,639 56,925 52,924 58,652 60,194 62,222 60,886 50,850

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kopran. Kopran dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.00 per unit for 2026-March, a yield of 1.04%, compared with ₹3.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.00, ₹3.00 and ₹3.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹3.00 1.04%
2025-March ₹3.00 2.78%
2024-March ₹3.00 1.71%
2023-March ₹3.00 1.16%
2022-March ₹3.00 2.97%
2021-March ₹3.00 1.07%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Kopran Stock Index Membership - Nifty & Sensex

See which indices include Kopran stock. Check KOPRAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 2 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE INDEX BSE HC
BSE INDEX SMLCAP

Kopran Market Events Screener - Corporate Actions

Get Kopran corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kopran stock events that may affect KOPRAN share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Annual General Meeting dated August 18, 2026 and Dividend dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA -2.00%
2026-08-18 2026-08-18 Annual General Meeting NA -2.13%
2026-08-11 2026-08-11 Dividend ₹ 3.00 /share 7.58%
2026-08-07 2026-08-07 Quarterly Result Announcement NA -6.54%
2026-06-03 2026-06-03 Extraordinary General Meeting NA 24.69%
2026-05-19 2026-05-19 Quarterly Result Announcement NA 1.91%
2026-01-22 2026-01-22 Quarterly Result Announcement NA -8.41%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -4.21%
2025-09-11 2025-09-11 Annual General Meeting NA 2.79%
2025-09-04 2025-09-04 Dividend ₹ 3.00 /share -10.53%
2025-07-29 2025-07-29 Quarterly Result Announcement NA -1.82%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 7.20%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -0.98%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 0.67%
2024-09-11 2024-09-11 Annual General Meeting NA 26.84%

Kopran Competitors Screener - Peer Stocks Comparison

Screen KOPRAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Kopran Company Announcements - News & Reports Screener

Screen KOPRAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 19, 2026.

Date Update Actions
2026-11-19 Volume Movement Letter -
2026-11-19 Clarification sought from Kopran Ltd -
2026-11-19 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-11-19 Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-11-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-03 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-03 Board Meeting Outcome for Result Q2 FY 2026-27 -
2026-11-03 Results For Second Quarter Ended September 30 2026 -
2026-10-26 Board Meeting Intimation for Unaudited Financial Results For Second Quarter Ended September 30 2026. -
2026-10-22 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-25 Closure of Trading Window -
2026-09-22 Announcement Under Regulation 30 (LODR) For Price Movement -
2026-09-21 Clarification sought from Kopran Ltd -
2026-09-16 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-08 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-01 Clarification For Increase In Scrip Volume -
2026-09-01 Clarification sought from Kopran Ltd -
2026-08-18 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹267.05, within a 52-week range of ₹108.04 to ₹290.90. The P/E ratio is 34.50 and the P/B ratio is 2.57, with earnings per unit of ₹5.33. Market capitalisation stands at ₹1,395.85 Cr and the dividend yield is 1.07%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.